Bharat Immunologicals Quarterly Results for Trading Insights
BIBCL • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-17 Cr
QMarch 2023
Bharat Immunologicals Quarterly Results Key Highlights
- Revenue of ₹47 Cr in March 2023 (+0.0% vs March 2023, -41.2% vs March 2022)
- Net Profit of ₹-17 Cr in March 2023 (+0.0% vs March 2023, -88.9% vs March 2022)
- EBITDA of ₹-16 Cr in March 2023 (+0.0% vs March 2023)
- Operating Margin of -41.0% in March 2023 (+0.0pp vs March 2023)
- Earnings Per Share of ₹-3.95 in March 2023 (+0.0% vs March 2023)
Bharat Immunologicals Quarterly Results Analysis
| Metric | 2026 | March 2023 | March 2022 | March 2021 | March 2020 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 9 | 47 | 80 | 87 | 68 | -80.9% | - |
| Net Profit (₹ Cr) | -18 | -17 | -9 | -18 | -10 | - | - |
| EBITDA (₹ Cr) | -17 | -16 | -4 | -19 | -9 | - | - |
| EPS (₹) | -4.20 | -3.95 | -2.03 | 1.10 | -2.36 | - | - |
| Operating Margin (%) | -13.0% | -41.0% | -6.0% | -24.0% | -16.0% | - | - |
Bharat Immunologicals Share Price Trend Around Quarterly Results
Visualize Bharat Immunologicals's 1-year price movement across quarterly results — ideal for logging trades in Bharat Immunologicals share price
chart using Tickjournal. All values in ₹.
Related Pages for Bharat Immunologicals
Additional stock information and data for BIBCL
Revenue Trend (₹ Cr)
March 2021
87
March 2022
80
March 2023
47
2026
9
Net Profit Trend (₹ Cr)
March 2021
-18
March 2022
-9
March 2023
-17
2026
-18
Operating Margin Trend (%)
March 2021
-24.0%
March 2022
-6.0%
March 2023
-41.0%
2026
-13.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Bharat Immunologicals quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1760.2 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.4 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3936.8 | 3,219 | 591 | +11.3% | - | 18.4% | 224.4 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1530.8 | 7,716 | 1,353 | +12.0% | - | 17.5% | 91.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1256.2 | 9,135 | 1,337 | +1.1% | - | 14.6% | 77.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores